Display options
Share it on

Exp Ther Med. 2019 Apr;17(4):2666-2674. doi: 10.3892/etm.2019.7242. Epub 2019 Feb 04.

Protective effect of ethyl vanillin against Aβ-induced neurotoxicity in PC12 cells via the reduction of oxidative stress and apoptosis.

Experimental and therapeutic medicine

Lei Zhong, Yuna Tong, Junlan Chuan, Lan Bai, Jianyou Shi, Yuxuan Zhu

Affiliations

  1. Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan 610072, P.R. China.
  2. Department of Nephrology, The Third People's Hospital of Chengdu, Chengdu, Sichuan 610031, P.R. China.

PMID: 30930969 PMCID: PMC6425458 DOI: 10.3892/etm.2019.7242

Abstract

Increased aggregation of β-amyloid (Aβ) peptides induces oxidative stress, which is considered a major contributor in the development of Alzheimer's disease (AD). Prevention of Aβ-induced neurotoxicity is proposed as a possible modality for treatment of AD. The present study aimed to elucidate possible effects of ethyl vanillin (EVA), an analog of vanillin isolated from vanilla beans, on the Aβ

Keywords: ethyl vanillin; neuroprotection; oxidative stress

References

  1. Physiol Rev. 2001 Apr;81(2):741-66 - PubMed
  2. Neurology. 2001 Oct 23;57(8):1422-7 - PubMed
  3. Free Radic Biol Med. 2002 May 1;32(9):797-803 - PubMed
  4. Science. 2002 Jul 19;297(5580):353-6 - PubMed
  5. Neurobiol Aging. 2002 Sep-Oct;23(5):655-64 - PubMed
  6. Neuroscience. 2002;115(1):201-11 - PubMed
  7. Neurochem Int. 2003 Aug;43(3):263-9 - PubMed
  8. Life Sci. 2004 Jul 23;75(10):1263-76 - PubMed
  9. Eur J Pharm Sci. 2005 May;25(1):57-65 - PubMed
  10. J Neural Transm (Vienna). 2006 May;113(5):645-57 - PubMed
  11. Neurochem Res. 2007 Apr-May;32(4-5):757-73 - PubMed
  12. Biol Pharm Bull. 2007 Feb;30(2):309-12 - PubMed
  13. Expert Rev Neurother. 2007 Nov;7(11):1517-25 - PubMed
  14. Brain Res. 2008 Jan 10;1188:1-8 - PubMed
  15. J Agric Food Chem. 2007 Dec 26;55(26):10962-7 - PubMed
  16. Behav Brain Res. 2008 Sep 1;192(1):106-13 - PubMed
  17. Eur J Pharmacol. 2008 Sep 4;591(1-3):21-7 - PubMed
  18. Neurosci Lett. 2008 Sep 12;442(2):143-7 - PubMed
  19. J Cell Mol Med. 2009 Sep;13(9A):2911-25 - PubMed
  20. Aging Cell. 2008 Oct;7(5):771-5 - PubMed
  21. J Pharmacol Exp Ther. 2009 Aug;330(2):370-6 - PubMed
  22. Alzheimers Dement. 2007 Jul;3(3):186-91 - PubMed
  23. J Neural Transm (Vienna). 2009 Nov;116(11):1371-81 - PubMed
  24. Arch Pharm Res. 2010 Feb;33(2):309-16 - PubMed
  25. Neurosci Lett. 2010 Oct 8;483(1):78-82 - PubMed
  26. Antioxid Redox Signal. 2011 Apr 15;14(8):1505-17 - PubMed
  27. Biochim Biophys Acta. 2011 Feb;1810(2):170-7 - PubMed
  28. Free Radic Biol Med. 2011 Sep 1;51(5):1014-26 - PubMed
  29. Eur J Pharmacol. 2011 Oct 1;668(1-2):133-9 - PubMed
  30. Environ Toxicol Pharmacol. 2011 Jan;31(1):233-41 - PubMed
  31. Int J Alzheimers Dis. 2011;2011:918280 - PubMed
  32. Cell Mol Neurobiol. 2012 Apr;32(3):353-60 - PubMed
  33. Biosci Biotechnol Biochem. 2011;75(12):2346-50 - PubMed
  34. Food Chem Toxicol. 2012 Jun;50(6):1897-901 - PubMed
  35. Biomacromolecules. 2013 May 13;14(5):1618-26 - PubMed
  36. J Med Food. 2013 Nov;16(11):977-83 - PubMed
  37. Free Radic Res. 2014 Feb;48(2):146-58 - PubMed
  38. Mol Pharm. 2014 Feb 3;11(2):428-35 - PubMed
  39. PLoS One. 2014 Feb 20;9(2):e89122 - PubMed
  40. Folia Neuropathol. 2014;52(3):285-90 - PubMed
  41. Minerva Med. 2016 Apr;107(2):108-13 - PubMed
  42. Neurochem Res. 2016 Aug;41(8):1899-910 - PubMed
  43. ACS Chem Neurosci. 2017 Jan 18;8(1):82-88 - PubMed
  44. J Alzheimers Dis. 2017;56(4):1469-1484 - PubMed
  45. Am Fam Physician. 2017 Jun 15;95(12):771-778 - PubMed
  46. Biomed Pharmacother. 2018 Feb;98:701-708 - PubMed
  47. Sci Rep. 2018 Jan 8;8(1):26 - PubMed
  48. Annu Rev Biochem. 1997;66:385-407 - PubMed
  49. Genes Cells. 1998 Nov;3(11):697-707 - PubMed

Publication Types